Evidence map›Paper›PMID 39087580›Full record

ArticleJMIR public health and surveillance2024

Key Characteristics and Perception of Different Outbreak Surveillance Systems in Côte d'Ivoire: Cross-Sectional Survey Among Users.

Marta S Palmeirim, Clarisse A Houngbedji, Tanja Barth-Jaeggi, Jean-Pierre Y Kouamé, Aboubakar Krouman, Daouda Coulibaly, Kaspar Wyss

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta S PalmeirimSwiss Center for International Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-4709-2489
Clarisse A HoungbedjiCentre d'Entomologie Médicale Et Véterinaire (CEMV), Université Alassane Ouattara, Bouaké, Cote D'Ivoire.ORCID 0000-0003-3222-9259
Tanja Barth-JaeggiSwiss Center for International Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-4453-5950
Jean-Pierre Y KouaméNational Institute of Public Hygiene, Abidjan, Cote D'Ivoire.ORCID 0009-0009-0204-4713
Aboubakar KroumanNational Institute of Public Hygiene, Abidjan, Cote D'Ivoire.ORCID 0009-0004-8647-8394
Daouda CoulibalyNational Institute of Public Hygiene, Abidjan, Cote D'Ivoire.ORCID 0000-0002-5432-9915
Kaspar WyssSwiss Center for International Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0003-0156-5989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate and timely infectious disease surveillance is pivotal for effective public health responses. An important component of this is the disease surveillance tools used. Understanding views and experiences of users is crucial for informing policy decisions and ensuring the seamless functioning of surveillance systems. Objective: In this study, we aimed to assess the user perceptions of 3 disease surveillance tools used in Côte d'Ivoire, namely, MAGPI, District Health Information Software 2 (DHIS2), and Surveillance Outbreak Response Management and Analysis System (SORMAS), the latter was implemented in 2021 within a pilot scheme. Methods: We conducted interviews and a web-based survey distributed to users of the 3 surveillance tools. The survey assessed users' views of the surveillance tools' usefulness, ease of use, feelings toward the tool, conditions that may influence the use, and other characteristics. The descriptive analysis compared responses from SORMAS, MAGPI, and DHIS2 users, providing a comprehensive evaluation of their experiences. Results: Among the 159 respondents who actively use one of the systems, MAGPI was the most widely used surveillance tool among respondents (n=127, 79.9%), followed by DHIS2 (n=108, 67.9%), and SORMAS (n=25, 15.7%). In terms of users' perceptions, SORMAS, despite its limited implementation, emerged as a tool that allows for data analysis and had the most comprehensive set of functionalities. DHIS2 was appreciated for its frequency of report provision, although users reported occasional IT system failures. MAGPI was recognized for its ease of use but was reported to lack certain functionalities offered by the other surveillance systems. Conclusions: This study offers valuable insights into the perceptions of disease surveillance tools users in Côte d'Ivoire. While all systems were positively regarded, each exhibited strengths and weaknesses addressing different needs and functionalities. Policy makers and health officials can use these findings to enhance existing tools or consider a unified approach for infectious disease surveillance systems. Understanding users' perspectives allows them to optimize the choice of surveillance tools, ultimately strengthening public health responses in Côte d'Ivoire and potentially serving as a model for other countries facing similar decisions in their health care systems.

Indexed as

Disease OutbreaksAdultCote d'IvoireCross-Sectional StudiesFemaleHumansMaleMiddle AgedPerceptionPopulation SurveillanceSurveys and QuestionnairesCôte d’IvoireCOVID-19cross-sectional studydescriptively analysisDHIS2disease surveillanceDistrict Health Information Software 2health care systemhealthcare systemhealth officialsinfectious diseaseinfectious diseaseskey characteristicsMAGPIoutbreak surveillanceoutbreak surveillance systempolicy decisionpolicy makersPolicymakerspublic healthSORMASSurveillance Outbreak Response Management and Analysis Systemusers’ perception

Identifiers

PMID39087580
PMCPMC11300380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.